Thermo Fisher Scientific (TMO)
(Delayed Data from NYSE)
$481.10 USD
+8.46 (1.79%)
Updated Sep 18, 2025 04:00 PM ET
After-Market: $481.01 -0.09 (-0.02%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth D Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
TMO 481.10 +8.46(1.79%)
Will TMO be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for TMO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TMO
Hologic's Strong International Traction to Continue Despite Headwinds
The New Olink Target 48 Neurodegeneration Panel May Boost TMO Stock
TMO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Beat the Market the Zacks Way: CommScope, Micron, Oracle in Focus
Hologic's Panther Fusion Signals More Molecular Diagnostics Upside
Why Is Idexx (IDXX) Down 0.4% Since Last Earnings Report?
Other News for TMO
Is TMO positioned for a breakdown? 20 Day Moving Average Resistance shows up after sinking 1.68%
Is TMO signaling a buying opportunity? Crossed Above 200 Day Moving Average shows up after climbing 1.32%
TMO forms 200 Day Moving Average Resistance on September 15
Thermo Fisher (TMO) Enhances U.S. Distribution for Harvard Bioscience Products
Harvard Bioscience expands distribution agreement with Fisher Scientific